Protein Assays Market Report 2026

The protein assays market size has grown rapidly in recent years. It will grow from $3.28 billion in 2025 to $3.77 billion in 2026 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to expansion of biomedical research activities, increasing use of proteins in drug development, rising adoption of laboratory automation, growth of clinical diagnostics testing, availability of standardized protein reagents.

The protein assays market size is expected to see rapid growth in the next few years. It will grow to $6.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing focus on personalized medicine research, rising demand for advanced proteomics tools, expansion of pharmaceutical R&D pipelines, growing adoption of automated laboratory workflows, increasing investments in life sciences research infrastructure. Major trends in the forecast period include increasing adoption of high-sensitivity assay kits, rising use of automated protein quantification instruments, growing demand for multiplex protein analysis, expansion of high-throughput screening applications, enhanced focus on assay accuracy and reproducibility.

The expansion of the pharmaceutical industry is expected to drive the growth of the protein assays market in the coming years. The pharmaceutical industry focuses on the research, development, manufacturing, and distribution of drugs and medications for disease prevention, diagnosis, and treatment. Growth in this industry is driven by factors such as increasing global healthcare demand, rising healthcare expenditure, and a stronger emphasis on preventive care. Protein assays play a vital role in pharmaceutical applications by enabling precise measurement of protein concentration and activity, which is essential for drug discovery, development, and quality control processes. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the European pharmaceutical industry, total pharmaceutical production in Europe reached €390.0 billion in 2023, up from €363.3 billion in 2022. Therefore, the growth of the pharmaceutical industry is driving the expansion of the protein assays market.

Major companies operating in the protein assays market are focusing on the development of advanced solutions such as high-plex proteomics platforms. A high-plex proteomics platform is a technology designed to measure a large number of proteins simultaneously within a single experiment. For instance, in November 2023, SomaLogic Inc., a US-based proteomics technology company, launched the SomaScan 11K Platform. This platform enables the measurement of 11,000 proteins, offering researchers a significant advantage in identifying biomarkers and potential drug targets for translational medicine. The addition of 3,500 proteins to the 11K assay is expected to reveal new biomarkers that were previously difficult to measure, supporting the development of more accurate diagnostic tools.

In October 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Holding for $3.1 billion. Through this acquisition, Thermo Fisher Scientific aims to strengthen its protein analysis and biomarker discovery capabilities by expanding its range of research and clinical tools and services. Olink Holding is a Sweden-based biotechnology company specializing in protein biomarker discovery and development.

Major companies operating in the protein assays market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Roche Diagnostics International AG, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, R And D Systems Inc, Lonza Group AG, PerkinElmer Inc, Bio Rad Laboratories Inc, Takara Bio Inc, Qiagen NV, Promega Corporation, Abcam plc, BioVision Inc, Cayman Chemical Company, Enzo Life Sciences Inc, Novus Biologicals LLC, Abnova Corporation, Elabscience Biotechnology Co Ltd, Geno Technology Inc, Cytoskeleton Inc.

North America was the largest region in the protein assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global protein assays market report during the forecast period. The regions covered in the protein assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the protein assays market by increasing the cost of imported reagents, assay kits, analytical instruments, optical components, and precision electronics used in spectrophotometers and microplate readers. Pharmaceutical and biotechnology laboratories in North America and Europe are most affected due to reliance on specialized imported consumables, while Asia-Pacific faces pricing pressure on assay kit exports. These tariffs are increasing operational costs and affecting procurement cycles for research institutions. However, they are also encouraging localized reagent manufacturing, regional instrument assembly, and stronger domestic supply chains for life science consumables.

The protein assays market research report is one of a series of new reports that provides protein assays market statistics, including protein assays industry global market size, regional shares, competitors with a protein assays market share, detailed protein assays market segments, market trends and opportunities, and any further data you may need to thrive in the protein assays industry. This protein assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein assays involve the measurement of the amount or concentration of proteins present in a sample, depending on the specific application. Many clinical and research workflows require the isolation and detection of proteins, and protein assays are used to quantify the presence of a single protein or multiple proteins within a sample.

The two primary product categories in the protein assays market are reagents and kits, and instruments. A reagent is a substance utilized for its chemical or biological activity in producing products, generating images, or detecting and measuring specific components. Protein assays employ a range of technologies, including absorbance-based assays, colorimetric assays, and fluorescence-based assays. These assays are widely used across end-user industries such as pharmaceuticals, biotechnology, clinical laboratories, hospitals, and academic research institutions.

The protein assay services market includes revenues earned by entities by providing different protein quantitation methods such as enzyme-linked immunosorbent assay (ELISA), western blot analysis, and more recently, mass spectrometry, among others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.